Moreover, the neuroinflammatory and neurodegenerative effects of the cGAS‐STING pathway may not be limited to PD, as evidenced by cGAS‐STING activation in other neurodegenerative diseases such as Huntington's disease, Niemann–Pick disease type C, ALS, and AD.18, 52, 53, 54. The gene discussed is CGAS; the disease is neurodegenerative disease.